Group One Trading’s OncoSec Medical Incorporated ONCS Stock Holding History

Group One Trading’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4	Closed	-$10	–	8521
2023 Q1	$10	Sell	4 -1	-20%	-$2	﹤0.01%	7092
2022 Q4	$8	Sell	5 -292	-98%	-$1.64K	﹤0.01%	7121
2022 Q3	$3K	Sell	297 -28	-9%	-$421	﹤0.01%	7096
2022 Q2	$5K	Sell	325 -9	-3%	-$173	﹤0.01%	7166
2022 Q1	$8K	Hold	334	–	–	﹤0.01%	7276
2021 Q4	$7K	Buy	+334	New	+$11.3K	﹤0.01%	7552

Group One Trading's ONCS Position: Q2 2023 in Review

Group One Trading sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 4 shares — an estimated $10 sold.

Group One Trading first reported a position in ONCS in Q4 2021 and held it in 6 quarters. The position peaked at $8K in Q1 2022. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.

Group One Trading reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 4 OncoSec Medical Incorporated shares in Q2 2023, an estimated $10.
Group One Trading first reported a position in OncoSec Medical Incorporated in Q4 2021 and held it in 6 quarters.
Group One Trading's OncoSec Medical Incorporated position peaked at $8K in Q1 2022.
0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.